Clinical Trial Update: Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia

View source ↗

Summary

Clinical trial update reporting on the efficacy of OLOMAX in reducing blood pressure and LDL cholesterol in hypertensive patients with dyslipidemia; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension

Drugs mentioned

• OLOMAX

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Hypertension, Dyslipidemias | Status: ACTIVE_NOT_RECRUITING